Glutamine is designated a non-essential amino acid: however, evidence
is accumulating that glutamine becomes essential when catabolic condit
ions prevail. It has been established that glutamine is an important f
uel for lymphocytes and macrophages, even when resting. Plasma and mus
cle glutamine concentrations are decreased after trauma such as burns,
major surgery, and in sepsis. The effectiveness of the immune system
is decreased after trauma: this may be due, in part, to the decrease i
n plasma glutamine concentrations. Most studies on sepsis in humans ha
ve shown plasma glutamine concentrations to be decreased: this may be
due to an increased rate of utilization of glutamine by lymphocytes an
d macrophages during proliferation or phagocytosis. In contrast, sever
al studies on rats show increased plasma glutamine levels in sepsis. A
species difference in the way in which glutamine is metabolised could
be the main reason for the conflicting results. Other contributory fa
ctors could be diurnal variation and timing of sample collection. A su
bstantial amount of dietary glutamine is taken up by intestinal cells.
When the supply of glutamine via the diet is decreased, glutamine is
taken up from the circulation by the intestine. In total parenteral nu
trition (TPN) sepsis can sometimes occur because the gut is ''rested''
, leading to villous atrophy and increased gut mucosal barrier permeab
ility. There is now a move towards the use of enteral nutrition in pre
ference to TPN. Provision of exogenous glutamine has had beneficial ef
fects in humans and animals, particularly in improving intestinal func
tion. The safety and efficacy of glutamine administration to humans is
discussed in detail.